Novonesis: Global uncertainty catalysing increased biosolutions demand
Ester Baiget, CEO of Novonesis discusses Q1 earnings, and explains why the company does not expect a significant impact from the Middle East conflict.
Ester Baiget, CEO of Novonesis discusses Q1 earnings, and explains why the company does not expect a significant impact from the Middle East conflict.